Brainstorm Cell Therapeutics Inc. Liquidation Value Calculator
Brainstorm Cell Therapeutics Inc.
Current Price: N/A
Loading calculator data...
Advanced: All 81 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| accounts_payable | ||||
| Accounts Payable Current total AccountsPayableCurrent |
$7.07M | USD | ||
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$29,000 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$276,000 | USD | ||
| Restricted Cash Noncurrent total RestrictedCashNoncurrent |
$247,000 | USD | ||
| current_liabilities | ||||
| Accrued Liabilities Current total AccruedLiabilitiesCurrent |
$396,000 | USD | ||
| Employee Related Liabilities Current total EmployeeRelatedLiabilitiesCurrent |
$2.37M | USD | ||
| Operating Lease Liability Current total OperatingLeaseLiabilityCurrent |
$208,000 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$11.01M | USD | ||
| liabilities_total | ||||
| Liabilities total | $11.01M | USD | ||
| operating_lease_liability | ||||
| Operating Lease Liability total OperatingLeaseLiability |
$208,000 | USD | ||
| Operating Lease Liability Current fact OperatingLeaseLiabilityCurrent |
$208,000 | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
11.0M | shares | ||
Unmapped Tags (66)
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | $3.20M | USD | ||
| Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock | $227.06M | USD | ||
| Assets Assets | $1.02M | USD | ||
| Assets Current AssetsCurrent | $307,000 | USD | ||
| Assets Noncurrent AssetsNoncurrent | $715,000 | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $250.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $11.03M | shares | ||
| Common Stock Value CommonStockValue | $16,000 | USD | ||
| Deferred Tax Assets Gross DeferredTaxAssetsGross | $64.22M | USD | ||
| Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance | $64.22M | USD | ||
| Lease Cost LeaseCost | $712,000 | USD | ||
| Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | $7,000 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $1.02M | USD | ||
| Nontrade Receivables Current NontradeReceivablesCurrent | $86,000 | USD | ||
| Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset | $208,000 | USD | ||
| Other Assets Noncurrent OtherAssetsNoncurrent | $25,000 | USD | ||
| Property Plant And Equipment Gross PropertyPlantAndEquipmentGross | $3.44M | USD | ||
| Property Plant And Equipment Net PropertyPlantAndEquipmentNet | $235,000 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-236.94M | USD | ||
| Stockholders Equity StockholdersEquity | $-9.98M | USD | ||
| Treasury Stock Common Value TreasuryStockCommonValue | $116,000 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $-95,000 | USD | ||
| Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade | $987,000 | USD | ||
| Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities | $716,000 | USD | ||
| Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability | $87,000 | USD | ||
| Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue | $215,000 | USD | ||
| Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | $215,000 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $6.88M | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-6.97M | USD | ||
| Operating Lease Payments OperatingLeasePayments | $712,000 | USD | ||
| Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock | $186.00M | USD | ||
| Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants | $1.50M | USD | ||
| Proceeds From Short Term Debt ProceedsFromShortTermDebt | $582,000 | USD | ||
| Share Based Compensation ShareBasedCompensation | $1.52M | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | $30,000 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | $2 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | $688,666 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | $2 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | $469,098 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | $3 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | $43,800 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | $51,656 | shares | ||
| Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation | $1.52M | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-1 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-1 | USD/shares | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $5.78M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | $-5.07M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | $-10.31M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | $-5.24M | USD | ||
| Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet | $-533,000 | USD | ||
| Net Income Loss NetIncomeLoss | $-10.31M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-9.95M | USD | ||
| Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent | $0 | pure | ||
| Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent | $192,000 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $4.17M | USD | ||
| Stock Option Plan Expense StockOptionPlanExpense | $1.52M | USD | ||
| Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent | $0 | pure | ||
| Depreciation Depreciation | $199,000 | USD | ||
| Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants | $-179,000 | USD | ||
| Number Of Reportable Segments NumberOfReportableSegments | $1 | segment | ||
| Operating Loss Carryforwards OperatingLossCarryforwards | $231.87M | USD | ||
| Profit Loss ProfitLoss | $-10.31M | USD | ||
| Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent | $0 | USD | ||
| Tax Credit Carryforward Amount TaxCreditCarryforwardAmount | $231.87M | USD | ||
| Warrants And Rights Outstanding WarrantsAndRightsOutstanding | $0 | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.